- Home
- SCLX vs WMPN Comparison
SCLX vs WMPN Comparison
Compare SCLX & WMPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- WMPN
- Stock Information
- Founded
- SCLX 2011
- WMPN 1870
- Country
- SCLX United States
- WMPN United States
- Employees
- SCLX N/A
- WMPN N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- WMPN Savings Institutions
- Sector
- SCLX Health Care
- WMPN Finance
- Exchange
- SCLX Nasdaq
- WMPN Nasdaq
- Market Cap
- SCLX 130.1M
- WMPN 112.6M
- IPO Year
- SCLX N/A
- WMPN N/A
- Fundamental
- Price
- SCLX $0.61
- WMPN $12.97
- Analyst Decision
- SCLX Strong Buy
- WMPN Buy
- Analyst Count
- SCLX 3
- WMPN 1
- Target Price
- SCLX $11.33
- WMPN $14.00
- AVG Volume (30 Days)
- SCLX 184.3K
- WMPN 86.0K
- Earning Date
- SCLX 11-26-2024
- WMPN 10-16-2024
- Dividend Yield
- SCLX N/A
- WMPN 0.93%
- EPS Growth
- SCLX N/A
- WMPN N/A
- EPS
- SCLX N/A
- WMPN N/A
- Revenue
- SCLX $50,833,000.00
- WMPN $20,360,000.00
- Revenue This Year
- SCLX $32.77
- WMPN N/A
- Revenue Next Year
- SCLX $50.71
- WMPN N/A
- P/E Ratio
- SCLX N/A
- WMPN N/A
- Revenue Growth
- SCLX 9.41
- WMPN N/A
- 52 Week Low
- SCLX $0.54
- WMPN $10.80
- 52 Week High
- SCLX $2.63
- WMPN $13.45
- Technical
- Relative Strength Index (RSI)
- SCLX 28.71
- WMPN 57.33
- Support Level
- SCLX $0.73
- WMPN $12.05
- Resistance Level
- SCLX $1.14
- WMPN $13.45
- Average True Range (ATR)
- SCLX 0.11
- WMPN 0.32
- MACD
- SCLX -0.04
- WMPN 0.03
- Stochastic Oscillator
- SCLX 11.99
- WMPN 65.71
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About WMPN William Penn Bancorporation
William Penn Bancorporation operates as an independent community financial services provider. The bank offers traditional banking and related financial services to individual, business, and government customers. Through its branch and automated teller machine network, the bank offers a full array of commercial and retail financial services, including; the taking of time, savings, and demand deposits; the making of commercial, consumer, and mortgage loans; and the providing of other financial services.